Development of small molecule TAM kinase inhibitors for treatment of cancer
Xiaodong Wang, Stephen V. Frye, H. Shelton Earp III, and Dmitri Kireev, University of North Carolina – Chapel Hill
Mediators of resistance to MERTK inhibition in acute myeloid leukemia
Jeff Tyner, BEAT AML Project, Oregon Health Sciences University
Therapeutic modeling using patient-derived 3D bone marrow biomimicry cultures
Nicki Panoskaltsis, Trinity College Dublin
Sakis Mantalaris, Trinity College Dublin
Targeting MERTK in the tumor immune microenvironment
Susan Thomas, Georgia Institute of Technology
Curtis Henry, University of Colorado